Nephrotic syndrome with diffuse membranous glomerulonephritis, unspecified
ICD-10 N04.20 is a billable code used to indicate a diagnosis of nephrotic syndrome with diffuse membranous glomerulonephritis, unspecified.
Nephrotic syndrome is characterized by a triad of symptoms: significant proteinuria, hypoalbuminemia, and edema. When associated with diffuse membranous glomerulonephritis, it indicates a specific type of kidney damage where the glomerular capillary walls become thickened due to immune complex deposition. This condition can lead to severe protein loss in urine, often exceeding 3.5 grams per day. Patients may present with symptoms such as swelling in the legs, abdomen, or around the eyes, and may also experience hematuria (blood in urine) and hypertension. Diagnosis typically involves a renal biopsy, which may reveal diffuse thickening of the glomerular membrane. Management of nephrotic syndrome often includes corticosteroids, diuretics for edema, and medications to control blood pressure and cholesterol levels. Regular monitoring of renal function and proteinuria is essential to assess treatment efficacy and disease progression.
Detailed renal function tests, biopsy results, and treatment plans.
Patients presenting with edema, proteinuria, and renal impairment.
Ensure clear documentation of the type of nephrotic syndrome and any comorbid conditions.
Comprehensive biopsy reports detailing glomerular changes.
Biopsy evaluations for suspected glomerulonephritis.
Accurate reporting of histological findings is crucial for coding.
Used when a renal biopsy is performed to confirm diagnosis.
Biopsy report and indication for the procedure.
Ensure nephrology documentation supports the need for biopsy.
Renal biopsy is crucial for diagnosing the specific type of glomerulonephritis, guiding treatment decisions, and assessing prognosis.
